Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 18632739)

1.

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.

Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL.

Cereb Cortex. 2009 Mar;19(3):497-510. doi: 10.1093/cercor/bhn113. Epub 2008 Jul 16.

2.

The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.

Bakkour A, Morris JC, Dickerson BC.

Neurology. 2009 Mar 24;72(12):1048-55. doi: 10.1212/01.wnl.0000340981.97664.2f. Epub 2008 Dec 24.

3.

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease.

Potter PE, Rauschkolb PK, Pandya Y, Sue LI, Sabbagh MN, Walker DG, Beach TG.

Acta Neuropathol. 2011 Jul;122(1):49-60. doi: 10.1007/s00401-011-0831-1. Epub 2011 May 1.

4.

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, Hyman BT, Blacker D, Detoledo-Morrell L.

Neurology. 2011 Apr 19;76(16):1395-402. doi: 10.1212/WNL.0b013e3182166e96. Epub 2011 Apr 13.

5.

The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition.

Bakkour A, Morris JC, Wolk DA, Dickerson BC.

Neuroimage. 2013 Aug 1;76:332-44. doi: 10.1016/j.neuroimage.2013.02.059. Epub 2013 Mar 16.

6.

Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Putcha D, Brickhouse M, O'Keefe K, Sullivan C, Rentz D, Marshall G, Dickerson B, Sperling R.

J Neurosci. 2011 Nov 30;31(48):17680-8. doi: 10.1523/JNEUROSCI.4740-11.2011.

7.

Variations in cortical thickness with dementia severity in Alzheimer's disease.

Im K, Lee JM, Seo SW, Yoon U, Kim ST, Kim YH, Kim SI, Na DL.

Neurosci Lett. 2008 May 9;436(2):227-31. doi: 10.1016/j.neulet.2008.03.032. Epub 2008 Mar 16.

PMID:
18400396
8.

Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.

Tosun D, Mojabi P, Weiner MW, Schuff N.

Neuroimage. 2010 Aug 1;52(1):186-97. doi: 10.1016/j.neuroimage.2010.04.033. Epub 2010 Apr 18.

PMID:
20406691
9.

Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.

Murphy KR, Landau SM, Choudhury KR, Hostage CA, Shpanskaya KS, Sair HI, Petrella JR, Wong TZ, Doraiswamy PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Sep;78:474-80. doi: 10.1016/j.neuroimage.2013.04.048. Epub 2013 Apr 23.

10.

Patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Richards BA, Chertkow H, Singh V, Robillard A, Massoud F, Evans AC, Kabani NJ.

Neurobiol Aging. 2009 Oct;30(10):1626-36. doi: 10.1016/j.neurobiolaging.2007.12.019. Epub 2008 Feb 7.

PMID:
18261828
11.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
12.

The dynamics of cortical and hippocampal atrophy in Alzheimer disease.

Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1040-8. doi: 10.1001/archneurol.2011.167.

13.

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.

Chance SA, Clover L, Cousijn H, Currah L, Pettingill R, Esiri MM.

Cereb Cortex. 2011 Aug;21(8):1870-8. doi: 10.1093/cercor/bhq264. Epub 2011 Jan 14.

14.

Accelerating cortical thinning: unique to dementia or universal in aging?

Fjell AM, Westlye LT, Grydeland H, Amlien I, Espeseth T, Reinvang I, Raz N, Dale AM, Walhovd KB; Alzheimer Disease Neuroimaging Initiative.

Cereb Cortex. 2014 Apr;24(4):919-34. doi: 10.1093/cercor/bhs379. Epub 2012 Dec 12.

15.

Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.

Dickerson BC, Wolk DA; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2013 Oct 11;5:55. doi: 10.3389/fnagi.2013.00055. eCollection 2013.

16.

Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW.

Brain. 2007 Apr;130(Pt 4):1159-66. Epub 2007 Mar 12.

17.

The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.

Prestia A, Baglieri A, Pievani M, Bonetti M, Rasser PE, Thompson PM, Marino S, Bramanti P, Frisoni GB.

Suppl Clin Neurophysiol. 2013;62:67-80.

PMID:
24053032
18.

Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.

Hatashita S, Yamasaki H.

J Alzheimers Dis. 2010;21(3):995-1003. doi: 10.3233/JAD-2010-100222.

PMID:
20693641
19.

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.

Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S329-47. doi: 10.3233/JAD-2012-129030. Review.

PMID:
22735677
20.

Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.

Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW.

Cereb Cortex. 2001 Jan;11(1):1-16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk